DHL Global Forwarding, the air and ocean freight forwarding arm of Deutsche Post DHL Group, has opened a dedicated pharmaceutical transport facility at the Indianapolis International Airport. The new facility, complementing an existing one in Plainfield, Indiana, bolsters an end-to-end temperature-controlled cargo service between Indianapolis and Brussels. This move solidifies central Indiana’s key role in life sciences, healthcare, and pharmaceutical transportation services.
- DHL Global Forwarding has launched a $1.5 million pharmaceutical transport facility at Indianapolis International Airport, boosting its pharmaceutical logistics capabilities.
- DHL’s new 30,000 sq ft pharmaceutical facility highlights its commitment to enhancing logistics capacity and efficiency in the life sciences sector.
- This investment strengthens central Indiana’s role as a key hub for life sciences, healthcare, and pharmaceutical logistics, potentially spurring regional economic growth.
Jose Maria de Orduna, the regional vice president of the U.S. East Region for DHL Global Forwarding, conveyed that Indiana holds a significant place as a pharmaceutical hub in the United States. His team is committed to assuring smooth and safe transportation of crucial products originating from this region, aiming to bolster their customers’ business growth in the area. He further stated that the investment they’ve made, combined with the expertise of their specialized life sciences and healthcare team in the U.S., is aimed at offering a distinctive end-to-end cold chain air cargo service. This service is designed to deliver both financial advantages and transit time benefits to their customers.
DHL Global Forwarding has announced the launch of a new $1.5 million pharmaceutical transportation facility at the Indianapolis International Airport. The 30,000-square-foot facility, strategically located with direct access to the airport ramp, enhances DHL’s existing ground handling operations by introducing the unit’s first temperature-controlled cargo service between Indianapolis and Brussels, Belgium.With a twice-weekly B777F air cargo freighter connection to Liege, Belgium, the new facility complements the company’s existing temperature-controlled life sciences facility in Plainfield, Indiana. The end-to-end process has been meticulously engineered to ship pharmaceuticals and life sciences products without the need for specialized temperature-controlled unit loading devices, ensuring quality control while delivering significant savings in transportation costs and time in transit. This expansion of DHL Global Forwarding’s operations in central Indiana further cements the region’s role as a vital hub for the development, manufacturing, and transportation services for the life sciences, health care, and pharmaceutical sectors.
DHL Global Forwarding is further extending its dedicated cold chain network in the U.S. market through this strategic investment. This follows recent advancements in two other life sciences hubs, namely San Juan, Puerto Rico, and North Carolina’s Research Triangle area. The company remains committed to strengthening its services in these key regions.